[1]
|
Berman DS. Noninvasive imaging in coronary artery disease. J Nucl Cardiol, 2006, 13(4):457-473. |
[2]
|
Slomka PJ, Nishina H, Berman DS, et al. "Motion-frozen" display and quantification of myocardial perfusion. J Nucl Med, 2004, 45(7):1128-1134. |
[3]
|
Berman DS, Hachamovitch R, Shaw LJ, et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance assessment of patients with suspected coronary artery disease. J Nucl Med, 2006, 47(1):74-82. |
[4]
|
Abidov A, Bax JJ, Hayes SW, et al. Transient ischemic dilation of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT results. J Am Coll Cardiol, 2003, 42(10):1818-1825. |
[5]
|
Cerqueira MD. Nuclear cardiology:finally a one-stop shop for diagno-sis, risk stratification, and management of coronary artery disease. Clin Cardiol, 2006, 29(9 Suppl 1):126-133. |
[6]
|
Shaw LJ, Hendel R, Borges-Neto S, et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging:results from the multicenter registry of 4,728 patients. J Nucl Med, 2003, 44(2):134-139. |
[7]
|
Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans:what is the warranty period of a normal scan?. J Am Coll Cardiol, 2003, 41(9):1329-1340. |
[8]
|
Valeti US, Miller TD, Hodge DO, et al. Exercise single-photon emission computed tomography provides effective risk stratification of elderly men and elderly women. Circulation, 2005, 111(14):1771-1776. |
[9]
|
Schinkel AF, Elhendy A, Biagini E, et at. Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing. J Nucl Med, 2005, 46(1):12-18. |
[10]
|
Chen EQ, Maclntyre WJ, Go RT, et al. Myocardial viability studies using fluorine-18-FDG SPECT:a comparison with fluorine-18-FDG PET. J Nucl Med, 1997, 38(4):582-586. |
[11]
|
Nishimura M, Hashimoto T, Kobayashi H, et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int, 2004, 66(2):811-819. |
[12]
|
Russell RR 3rd, Zaret BL.Nuclear cardiology:Present and future.Curr Probl Cardiol, 2006, 31(9):557-629. |
[13]
|
Gerson MC, McGuire N, Wagoner LE. Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy. J Card Fail, 2003, 9(5):384-391. |
[14]
|
Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease:consensus statement from the cardiac imaging committee, council on clinical cardiology, and the cardiovascular imaging and intervention committee, council on cardiovascular radiology and intervention, american heart association. Circulation. 2005, 111(5):682-696. |
[15]
|
Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation, 2003, 1079(23):2900-2907. |
[16]
|
De Lorenzo A, Lima RS, Siqueira-Filho AG, et al. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol, 2002, 90(8):827-832. |
[17]
|
Sciagra R, Giaccardi M, Porciani MC, et al. Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med, 2004, 45(2):164-168. |
[18]
|
Dussol B, Bonnet JL, Sampol J, et al. Prognostic value of inducible myocardial ischemia in predicting cardiovascular events after renal transplantation. Kidney Int, 2004, 66(4):1633-1639. |
[19]
|
Hase H, Joki N, Ishikawa H, et al. Prognostie value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant, 2004, 19(5):1161-1167. |
[20]
|
Noel Bairey Merz C,Shaw LJ, Reis SE, et al. Insights from the NHBLI sponsored Women's Ischaemic Syndrome Evaluation (WISE) study Part Ⅱ. J Am Coll Cardiol, 2006, 47(Suppl):21S-29S. |
[21]
|
Naidoo VV. Review of gated SPECT imaging in women with suspected coronary heart disease. J Nucl Cardiol, 2006, 13(4):474-479. |